Ecubectedin is a novel transcriptional inhibitor that displays potent antitumor effects in vitro and in vivo

被引：0
|
作者：
Nunez, Gema Santamaria
Diez, Marta Martinez
Guillen, Maria Jose
Garrido-Martin, Eva Maria
Aviles, Pablo
Cuevas, Carmen
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1622
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1622
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A novel bis-indole destabilizes microtubules and displays potent in vitro and in vivo antitumor activity in prostate cancer
    Sunjoo Ahn
    Dong Jin Hwang
    Christina M. Barrett
    Jun Yang
    Charles B. Duke
    Duane D. Miller
    James T. Dalton
    [J]. Cancer Chemotherapy and Pharmacology, 2011, 67 : 293 - 304
  • [2] A novel bis-indole destabilizes microtubules and displays potent in vitro and in vivo antitumor activity in prostate cancer
    Ahn, Sunjoo
    Hwang, Dong Jin
    Barrett, Christina M.
    Yang, Jun
    Duke, Charles B., III
    Miller, Duane D.
    Dalton, James T.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (02) : 293 - 304
  • [3] I-387, a Novel Antimitotic Indole, Displays a Potent In vitro and In vivo Antitumor Activity with Less Neurotoxicity
    Ahn, Sunjoo
    Duke, Charles B., III
    Barrett, Christina M.
    Hwang, Dong Jin
    Li, Chien-Ming
    Miller, Duane D.
    Dalton, James T.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2010, 9 (11) : 2859 - 2868
  • [4] Withaferin-A is a novel HSF-1 inhibitor with potent antitumor effects in melanoma in vivo
    Samadi, Abbas K.
    Mukerji, Ridhwi
    Shah, Anuj
    Bron, Tyler
    Timmermann, Barbara N.
    Cohen, Mark S.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [5] Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: In vitro and in vivo characterization
    Delpy, E
    deGouville, ACL
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (06) : 1377 - 1384
  • [6] CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivo
    Hjarnaa, PJV
    Jonsson, E
    Latini, S
    Dhar, S
    Larsson, R
    Bramm, E
    Skov, T
    Binderup, L
    [J]. CANCER RESEARCH, 1999, 59 (22) : 5751 - 5757
  • [7] Discovery of the Novel mTOR Inhibitor and Its Antitumor Activities In Vitro and In Vivo
    Xie, Hua
    Lee, Mee-Hyun
    Zhu, Feng
    Reddy, Kanamata
    Huang, Zunnan
    Kim, Dong Joon
    Li, Yan
    Peng, Cong
    Lim, Do Young
    Kang, Soouk
    Jung, Sung Keun
    Li, Xiang
    Li, Haitao
    Ma, Weiya
    Lubet, Ronald A.
    Ding, Jian
    Bode, Ann M.
    Dong, Zigang
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (06) : 950 - 958
  • [8] Potent in vitro and in vivo antitumor effects of MDM2 inhibitor nutlin-3 in gastric cancer cells
    Endo, Shinji
    Yamato, Kenji
    Hirai, Sachiko
    Moriwaki, Toshikazu
    Fukuda, Kuniaki
    Suzuki, Hideo
    Abei, Masato
    Nakagawa, Ichiro
    Hyodo, Ichinosuke
    [J]. CANCER SCIENCE, 2011, 102 (03) : 605 - 613
  • [9] OTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models
    Berenguer-Daize, Caroline
    Astorgues-Xerri, Lucile
    Odore, Elodie
    Cayol, Mylene
    Cvitkovic, Esteban
    Noel, Kay
    Bekradda, Mohamed
    MacKenzie, Sarah
    Rezai, Keyvan
    Lokiec, Francois
    Riveiro, Maria E.
    Ouafik, L'Houcine
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (09) : 2047 - 2055
  • [10] GuiErBai: a potent inhibitor, exhibiting broadly antitumor effect against cervical cancer in vitro and in vivo
    Qin, Hong-en
    Peng, Lei
    Xu, Yuan-cui
    Zhang, Zi-xiong
    Tian, Ren-fu
    Wan, Zhong-xian
    Pu, Dao-jing
    Li, Hong-chun
    Wu, Fei
    Zheng, Liangdong
    Xu, Xian-shun
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
12345